Kenvue Inc (KVUE)
Kenvue Inc. is a consumer health company whose common stock is listed on the New York Stock Exchange under the symbol KVUE. The company operates across the United States, the rest of North America, Europe, the Middle East, Africa, the Asia-Pacific region, and Latin America. Its business is organized into three segments: Self Care, Skin Health and Beauty, and Essential Health.
Kenvue’s product portfolio includes over-the-counter medicines for cough, cold and allergy relief, pain care, digestive health, smoking cessation, and eye care, along with naturally inspired self-care products, digital diagnostics, and telemedicine. It also markets face and body care, hair care, sun care, oral care, baby care, women’s health, wound care, tampons, cosmetics, vitamins, and supplements. The company sells products under a broad range of brands, including Benadryl, Tylenol, Zyrtec, Aveeno, Neutrogena, Listerine, BAND-AID, and Johnson’s. Incorporated in 2022, Kenvue is headquartered in Summit, New Jersey.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-KVUE
|
$20.94
|
17.6% Upside
|
Fair
|
$19.50
|
9.5% Upside
|
Fair
|
Fair
|
September 21, 2026
|
October 2, 2026
|
4.7%
|
November 11, 2026
|
20.6x
|
3.2x
|
2.2x
|
34.209 B
|
41.712 B
|
20.1%
|
99.9%
|
4.1
|
96.0%
|
115.4%
|
